[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100507051":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":35,"centralContacts":35,"locations":36,"responsibleParty":201,"collaborators":35,"id":203,"slug":204,"hasResults":205,"nctId":206,"briefTitle":207,"officialTitle":208,"acronym":35,"eligibilityCriteria":209,"healthyVolunteers":205,"sex":210,"minAge":211,"maxAge":212,"enrollmentInfo":213,"targetDuration":35,"studyType":216,"phases":217,"briefSummary":219,"conditions":220,"keywords":35,"overallStatus":222,"whyStopped":35,"lastUpdateSubmitDate":223,"lastUpdatePostDateStruct":224,"startDateStruct":226,"completionDateStruct":228,"leadSponsor":230,"locationsCount":231},{"fullName":5,"class":6},"Vertex Pharmaceuticals Incorporated","INDUSTRY",[8,15],{"label":9,"type":10,"description":11,"interventionNames":12},"Part A","EXPERIMENTAL","Participants will receive ELX\u002FTEZ\u002FIVA in the morning and IVA in the evening.",[13,14],"Drug: ELX\u002FTEZ\u002FIVA","Drug: IVA",{"label":16,"type":10,"description":17,"interventionNames":18},"Part B","Participants will receive ELX\u002FTEZ\u002FIVA in the morning and IVA in the evening with the dose(s) to be based on the outcome of Part A.",[13,14],[20,28],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DRUG","ELX\u002FTEZ\u002FIVA","Fixed-dose combination granules for oral administration.",[9,16],[26,27],"VX-445\u002FVX-661\u002FVX-770","elexacaftor\u002Ftezacaftor\u002Fivacaftor",{"type":21,"name":29,"description":30,"armGroupLabels":31,"otherNames":32},"IVA","Granules for oral administration",[9,16],[33,34],"VX-770","ivacaftor",null,[37,48,56,64,72,82,90,100,110,118,126,136,146,154,164,172,180,188,193],{"facility":38,"status":35,"city":39,"state":35,"zip":35,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":35},"Telethon Kids Institute","Nedlands","Australia","AU",{"type":43,"coordinates":44},"Point",[45,46],115.8073,-31.98184,{"lat":46,"lon":45},{"facility":49,"status":35,"city":50,"state":35,"zip":35,"country":40,"countryCode":41,"cosmosGeoPoint":51,"geoPoint":55,"contacts":35},"The Royal Children's Hospital","Parkville",{"type":43,"coordinates":52},[53,54],144.95,-37.78333,{"lat":54,"lon":53},{"facility":57,"status":35,"city":58,"state":35,"zip":35,"country":40,"countryCode":41,"cosmosGeoPoint":59,"geoPoint":63,"contacts":35},"Queensland Children's Hospital","South Brisbane",{"type":43,"coordinates":60},[61,62],153.02049,-27.48034,{"lat":62,"lon":61},{"facility":65,"status":35,"city":66,"state":35,"zip":35,"country":40,"countryCode":41,"cosmosGeoPoint":67,"geoPoint":71,"contacts":35},"The Children's Hospital at Westmead","Westmead",{"type":43,"coordinates":68},[69,70],150.98768,-33.80383,{"lat":70,"lon":69},{"facility":73,"status":35,"city":74,"state":35,"zip":35,"country":75,"countryCode":76,"cosmosGeoPoint":77,"geoPoint":81,"contacts":35},"The Hospital for Sick Children","Toronto","Canada","CA",{"type":43,"coordinates":78},[79,80],-79.39864,43.70643,{"lat":80,"lon":79},{"facility":83,"status":35,"city":84,"state":35,"zip":35,"country":75,"countryCode":76,"cosmosGeoPoint":85,"geoPoint":89,"contacts":35},"British Columbia Children's Hospital","Vancouver",{"type":43,"coordinates":86},[87,88],-123.11934,49.24966,{"lat":88,"lon":87},{"facility":91,"status":35,"city":92,"state":35,"zip":35,"country":93,"countryCode":94,"cosmosGeoPoint":95,"geoPoint":99,"contacts":35},"Juliane Marie Center, Rigshospitalet","Copenhagen","Denmark","DK",{"type":43,"coordinates":96},[97,98],12.56553,55.67594,{"lat":98,"lon":97},{"facility":101,"status":35,"city":102,"state":35,"zip":35,"country":103,"countryCode":104,"cosmosGeoPoint":105,"geoPoint":109,"contacts":35},"Charite Paediatric Pulmonology Department","Berlin","Germany","DE",{"type":43,"coordinates":106},[107,108],13.41053,52.52437,{"lat":108,"lon":107},{"facility":111,"status":35,"city":112,"state":35,"zip":35,"country":103,"countryCode":104,"cosmosGeoPoint":113,"geoPoint":117,"contacts":35},"Kinderklinik III, Abt. fur Pneumologie","Essen",{"type":43,"coordinates":114},[115,116],7.01228,51.45657,{"lat":116,"lon":115},{"facility":119,"status":35,"city":120,"state":35,"zip":35,"country":103,"countryCode":104,"cosmosGeoPoint":121,"geoPoint":125,"contacts":35},"Medizinische Hochschule Hannover","Hanover",{"type":43,"coordinates":122},[123,124],9.73322,52.37052,{"lat":124,"lon":123},{"facility":127,"status":35,"city":128,"state":35,"zip":35,"country":129,"countryCode":130,"cosmosGeoPoint":131,"geoPoint":135,"contacts":35},"Erasmus Medical Center \u002F Sophia Children's Hospital","Rotterdam","Netherlands","NL",{"type":43,"coordinates":132},[133,134],4.47917,51.9225,{"lat":134,"lon":133},{"facility":137,"status":35,"city":138,"state":35,"zip":35,"country":139,"countryCode":140,"cosmosGeoPoint":141,"geoPoint":145,"contacts":35},"Inselspital - Universitaetsspital Bern","Bern","Switzerland","CH",{"type":43,"coordinates":142},[143,144],7.44744,46.94809,{"lat":144,"lon":143},{"facility":147,"status":35,"city":148,"state":35,"zip":35,"country":139,"countryCode":140,"cosmosGeoPoint":149,"geoPoint":153,"contacts":35},"Kinderspital Zuerich","Zurich",{"type":43,"coordinates":150},[151,152],8.55,47.36667,{"lat":152,"lon":151},{"facility":155,"status":35,"city":156,"state":35,"zip":35,"country":157,"countryCode":158,"cosmosGeoPoint":159,"geoPoint":163,"contacts":35},"Children and Young Adults Research Unit","Cardiff","United Kingdom","UK",{"type":43,"coordinates":160},[161,162],-3.18,51.48,{"lat":162,"lon":161},{"facility":165,"status":35,"city":166,"state":35,"zip":35,"country":157,"countryCode":158,"cosmosGeoPoint":167,"geoPoint":171,"contacts":35},"Leeds General Infirmary","Leeds",{"type":43,"coordinates":168},[169,170],-1.54785,53.79648,{"lat":170,"lon":169},{"facility":173,"status":35,"city":174,"state":35,"zip":35,"country":157,"countryCode":158,"cosmosGeoPoint":175,"geoPoint":179,"contacts":35},"Alder Hey Children's NHS Foundation Trust","Liverpool",{"type":43,"coordinates":176},[177,178],-2.97794,53.41058,{"lat":178,"lon":177},{"facility":181,"status":35,"city":182,"state":35,"zip":35,"country":157,"countryCode":158,"cosmosGeoPoint":183,"geoPoint":187,"contacts":35},"Great Ormond Street Hospital for Children","London",{"type":43,"coordinates":184},[185,186],-0.12574,51.50853,{"lat":186,"lon":185},{"facility":189,"status":35,"city":182,"state":35,"zip":35,"country":157,"countryCode":158,"cosmosGeoPoint":190,"geoPoint":192,"contacts":35},"Royal Brompton Hospital",{"type":43,"coordinates":191},[185,186],{"lat":186,"lon":185},{"facility":194,"status":35,"city":195,"state":35,"zip":35,"country":157,"countryCode":158,"cosmosGeoPoint":196,"geoPoint":200,"contacts":35},"Southampton General Hospital","Southampton",{"type":43,"coordinates":197},[198,199],-1.40428,50.90395,{"lat":199,"lon":198},{"type":202,"investigatorFullName":35,"investigatorTitle":35,"investigatorAffiliation":35,"oldNameTitle":35,"oldOrganization":35},"SPONSOR","100507051","phase-3-evaluation-of-elexacaftortezacaftorivacaftor-elxteziva-in-cystic-fibrosis-cf-participants-12-to-less-than-24-months-of-age-100507051",false,"NCT05882357","Evaluation of Elexacaftor\u002FTezacaftor\u002FIvacaftor (ELX\u002FTEZ\u002FIVA) in Cystic Fibrosis (CF) Participants 12 to Less Than 24 Months of Age","A Phase 3, Open-label Study Evaluating the Pharmacokinetics, Safety, and Tolerability of Elexacaftor\u002FTezacaftor\u002FIvacaftor in Cystic Fibrosis Subjects 12 to Less Than 24 Months of Age","Key Inclusion Criteria:\n\nParticipants who have at least 1 F508del mutation in the CF transmembrane conductance regulator (CFTR) gene or another ELX\u002FTEZ\u002FIVA-responsive CFTR mutation\n\nKey Exclusion Criteria:\n\nHistory of any illness or any clinical condition that, in the opinion of the investigator, might either confound the results of the study or pose an additional risk in administering study drug(s) to the participant\n\nOther protocol defined Inclusion\u002FExclusion criteria may apply.","ALL","12 Months","24 Months",{"count":214,"type":215},70,"ACTUAL","INTERVENTIONAL",[218],"PHASE3","This study will evaluate the pharmacokinetics (PK), safety, tolerability, pharmacodynamics (PD), and efficacy of ELX\u002FTEZ\u002FIVA in CF subjects 12 to less than (\\\u003C) 24 months of age.",[221],"Cystic Fibrosis","COMPLETED","2025-10-03",{"date":225,"type":215},"2025-10-06",{"date":227,"type":215},"2023-06-27",{"date":229,"type":215},"2025-09-04",{"name":5,"class":6},19]